Biostatistics & Bioinformatics News

Federal funding has provided crucial support for biomedical research at American universities for decades, fueling the innovation and discovery necessary to solve the biggest health challenges. This explainer video describes how research saves lives and how the process of research funding works.

Congratulations to the following doctoral students who have successfully defended their dissertations and will graduate from the Biostatistics PhD Program.

Jessica Tenenbaum, PhD , associate professor of biostatistics and bioinformatics, and

Biostatistics PhD student Zhuoran Hou has been selected to learn about oncology drug development and regulatory policy through the FDA-O

This fall, the Duke Department of Biostatistics & Bioinformatics welcomed a new cohort of PhD students in Computational Biology and Bioinformatics. Hailing from across the globe, these scholars bring impressive academic backgrounds, a passion for translational research, and a wide range of personal interests, from anime and marathons to K-pop and cooking.

This fall, the Department of Biostatistics and Bioinformatics welcomed a new cohort of PhD students in biostatistics. This accomplished group brings a wide range of academic backgrounds, research interests, and personal passions to the department. Their dedication to advancing health through data science and their enthusiasm for collaborative, interdisciplinary work will enrich the Duke community.

Researchers at Duke University School of Medicine have developed a powerful new tool that can detect cells that play a significant role in aging, known as senescent cells, with remarkable accuracy across a wide range of tissues and technologies.

Michael Pencina, PhD, stepped down as vice dean for data science at Duke University School of Medicine and chief data scientist for Duke Health, effective September 30, 2025. He accepted an exciting new opportunity as chief AI scientist with UnitedHealth Group

A data-driven shift at Duke Urology slashed wait times for men’s health appointment by focusing on the toughest prostate cancer and infertility cases first.

Thyroid cancer is common, but many cases — up to 77% — are believed to be over diagnosed.